Concepedia

Karla Alaka

KA

14

Publications

1.3K

Citations

13

H-Index

1992

Active since

Affiliations

Eli Lilly (United States)(Current)

Indiana University – Purdue University Indianapolis

Indiana University School of Medicine

Eli Lilly (United Kingdom)

University of Wisconsin–Madison

Karla Alaka is an author at Eli Lilly (United States) specializing in medicine, pharmacotherapy, and chronic kidney disease.

Top concepts

Publications per year

1992–2019

14

Publications

14

Double-Blind, Placebo-Controlled Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in the Treatment of Acute Agitation in Schizophrenia

Pádraig Wright, Martin Birkett, S.R. David et al. · American Journal of Psychiatry · 2001 · 301 citations

Duloxetine Versus Placebo in Patients With Chronic Low Back Pain: A 12-Week, Fixed-Dose, Randomized, Double-Blind Trial

Vladimir Skljarevski, Shuyu Zhang, D. Desaiah et al. · Journal of Pain · 2010 · 188 citations

, , +12

A comparison of metabolic control by continuous and intermittent therapies in acute renal failure.

William R. Clark, Bruce A. Mueller, Karla Alaka et al. · Journal of the American Society of Nephrology · 1994 · 164 citations

, , +21

Impact of the Nutritional Regimen on Protein Catabolism and Nitrogen Balance in Patients With Acute Renal Failure

William L. Macias, Karla Alaka, Mary H. Murphy et al. · Journal of Parenteral and Enteral Nutrition · 1996 · 118 citations

Calming versus sedative effects of intramuscular olanzapine in agitated patients

John Battaglia, Stacy Lindborg, Karla Alaka et al. · The American Journal of Emergency Medicine · 2003 · 105 citations

, , +10

Rows per page

1–5 of 14